This is the fourth article in our “Strategies for Winning Deals” series, which highlights ways that private equity sponsors can gain a competitive edge in buyouts without overpaying In today’s ...

Pharma innovators have long pursued a variety of deal structures to navigate the risks associated with the drug development process. Here we explore the legal and regulatory dynamics of these creative ...